The global Specific Pathogen Free (SPF) Animals Market is expected to grow stupendously in the upcoming period. This could be credited to extensive research being carried out in medical field owing to incidences of chronic diseases. Specific pathogen-free animals refer to an exclusive stock or group of animals kept under strict observation so as to ensure that they are devoid of contamination. It needs to be noted that once these animals are removed from bio-secure facility they lose their “specific pathogen free animals” status.
North America leads the market; followed by Europe. Growth in these geographies is due to presence of loads of contract research organizations (CROs) and research institutes. Besides, government bodies are increasing funding for facilitating vaccines for various diseases. To experiment with these vaccines, animals absolutely free of contaminations/diseases are required. This is another factor driving the market herein.
Asia Pacific is expected to grow at the fastest pace in the near future; thanks to economies like South Korea, India, and China showing significant growth due to emerging market for biotechnology. The latest trend catching up on this count is use of SPF eggs for making vaccines. At the same time, hidden risk associated with SPF animals can’t be ignored as only specific pathogens are diagnosed for. This could act as a restraint as presence of pathogens other than the one diagnosed goes unnoticed.
Access full report on global Specific Pathogen Free (SPF) Animals Market: https://www.millioninsights.com/industry-reports/specific-pathogen-free-spf-animals-market
• The geographies in line are North America, Europe, and Asia Pacific.
• Growing number of diseases are likely to drive the market.
• The players contributing to the market include Australian BioResources; Vivo Bio tech Ltd.; Envigo; Charles River laboratories International, Inc.; and The Jackson Laboratory.
Research Support Specialist, USA
Email: [email protected]